05:50 , Jun 2, 2018 |  BioCentury  |  Product Development

Breaking from the herd

Behind the block of clinical studies on PD-1 and PD-L1 inhibitors, researchers are casting aside their herd mentality with a wide net of strategies to solve some of the most pressing problems in oncology, such...
07:00 , Jun 11, 2007 |  BC Week In Review  |  Clinical News

Aimpila cancer data

In a 12-patient study, monotherapy with Aimpila produced 2 complete responses, 1 partial response and 3 cases of stable disease. Data were presented at the American Society of Clinical Oncology meeting in Chicago. Constab Pharmaceuticals...